FIELD: medicine, cardiology.
SUBSTANCE: in addition to the complex of conventional therapy it is necessary to introduce actovegin by the following scheme: intravenously at the dosage of 800 mg once daily for 21 d, then intramuscularly at the dosage of 400 mg twice daily for about 18-24 d, then in the form of dragee that contains 200 mg actovegin per 2 dragee four times daily for 15 d, and 3 mo later one should repeatedly introduce actovegin per 2 dragee twice or thrice daily for 15 d. The innovation provides efficient therapy of ischemic cardiac disease due to improved microcirculation and normalization of metabolic myocardial processes.
EFFECT: higher efficiency of therapy.
2 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING PATIENTS FOR GASTRIC AND DUODENAL PEPTIC ULCER AGGRAVATED WITH CARDIAC ISCHEMIA DISEASE | 2005 |
|
RU2288728C2 |
| METHOD FOR TREATING PATIENTS WITH NON-INSULIN DEPENDENT DIABETES MELLITUS (TYPE II) | 2004 |
|
RU2282453C2 |
| METHOD FOR TREATMENT OF PATIENT WITH ULCEROUS DISEASES COMBINED WITH DIABETES MELLITUS | 2004 |
|
RU2278676C1 |
| METHOD FOR TREATING ACUTE CORONARY SYNDROME | 2005 |
|
RU2294197C1 |
| METHOD FOR TREATING MYOCARDIAL INFARCTION | 2005 |
|
RU2294206C2 |
| METHOD FOR TREATING MYOCARDIAL INFARCTION | 2003 |
|
RU2245162C2 |
| METHOD FOR THE PREVENTION OF RECURRENT MYOCARDIAL INFARCTION IN PATIENTS WITH CORONARY HEART DISEASE (CHD) AFTER ACUTE CORONARY SYNDROME AND CARDIOVASCULAR SURGERY | 2021 |
|
RU2757965C1 |
| METHOD FOR IDENTIFICATION LONG-TERM MORTALITY RISK AND NEFTAL CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | 2017 |
|
RU2649964C1 |
| METHOD FOR TREATING DOGS WITH DILATED CARDIOMYOPATHY COMPLICATED BY CONGESTIVE CARDIAC FAILURE | 2020 |
|
RU2762989C1 |
| WAY OF CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2359686C2 |
